Equus Total Return (EQS) Kompaniya qiymatining sof foydaga nisbati

Equus Total Return Inc (EQS) korporativ emblemasi va logotipi

Equus Total Return, Inc. (EQS) barqarorlik tamoyillarini o'zining xususiy aktivlar tahliliga integratsiya qilgan holda, operatsiyalarining uglerod izini minimallashtirmoqda. Fond kichik bizneslar uchun infratuzilmani rivojlantirib, o'sishni nazorat qilish uchun kreditlashni aksiyadorlik egaligi bilan birlashtirmoqda. Joriy aksiya narxlarining ushbu grafigi -0.40 miqdoridagi P/E koeffitsiyentini aks ettiradi. Kelajakka nazar tashlasak, qarz majburiyatlari va muvofiqlikni avtomatlashtirilgan monitoring uchun AI modellarining joriy etilishi biznesning kengayish imkoniyatlarini oshiradi.

equuscap.com (EQS) Narx-foyda koeffitsiyenti: 11.10.2025 - 12.11.2026 davri uchun

Equus Total Return, Inc. kompaniyasining tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning umumiy tahlili:EQS, equuscap.com
Equus Capital original mahsuloti

P/E koeffitsiyenti aksiyaning bozor qiymatining bir aksiyaga to'g'ri keladigan foyda nisbati orqali aniqlanadi va aktivning baholanishi sof foyda yaratish samaradorligiga bog'liqligini aks ettiradi. Ushbu metrika investitsiyalarning qoplanish muddatini o'lchaydi, bu esa Equus Total Return (EQS) BDC kompaniyasi uchun bevosita AQSh o'rta bozor bizneslarining kredit foizlariga bog'liq; shuning uchun, biznesning joriy P/E koeffitsiyenti bozor narxining uning dividend potentsialiga nisbatan adolatli ekanligini baholash imkonini beradi.

Muhim raqobatchilar

Kapitalizatsiyaning foydaga nisbati arescapitalcorp.com ARCC|Narxning foydaga nisbati Blue Owl Capital (OBDC)|MAIN (Main Street Capital Corp) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati FS KKR FSK|Biznesning o‘zini qoplash muddati Golub Capital BDC Corp (GBDC)|TSLX: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati GSBD (Goldman Sachs BDC)|PSEC: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Capital Southwest Corp (CSWC)|Narxning foydaga nisbati Oaktree BDC|TRIN - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narx-foyda koeffitsiyenti MFIC (MidCap Financial Investment)|P/E multiplikatori newmountainfinance.com (NMFC)|P/E multiplikatori CGBD (Carlyle Secured Lending, Inc.)|Biznesning o‘zini qoplash muddati PennantPark Floating Rate Capital Ltd. (PFLT)|BBDC: Narx-foyda koeffitsiyenti|Bain Capital - Bozor narxining sof foydaga nisbati|SLRC (SLR Investment Corp.) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati fdus.com (FDUS)|MSIF (MSC Income Fund) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Crescent Capital BDC Inc CCAP|Narxning foydaga nisbati Gladstone Investment BDC (GAIN)|Gladstone Capital Corp. (GLAD) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|CION Investment - Narx-foyda koeffitsiyenti|P/E multiplikatori pennantpark.com PNNT|PSBD: Narx-foyda koeffitsiyenti|SAR - P/E multiplikatori|Runway Growth BDC (RWAY) - Narxning foydaga nisbati|TPVG - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti WHF|SWKH: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti GECC (Great Elm Capital Corp.)|Bozor narxining sof foydaga nisbati OFS|Narxning foydaga nisbati PhenixFIN PFX|Rand Capital Inc (RAND) - Kapitalizatsiyaning foydaga nisbati|ICMB: Narx-foyda koeffitsiyenti|loganridgefinance.com - Bozor narxining sof foydaga nisbati